Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.568
-0.143 (-3.84%)
Dec 19, 2025, 12:50 PM EST - Market open
Apyx Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Apyx Medical stock have a consensus rating of "Strong Buy" and an average price target of $7.00, which forecasts a 96.22% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $8.00.
Price Target: $7.00 (+96.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth Capital | Roth Capital | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +68.19% | Dec 16, 2025 |
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +124.25% | Nov 12, 2025 |
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +40.15% | Nov 10, 2023 |
Financial Forecast
Revenue This Year
52.19M
from 48.10M
Increased by 8.50%
Revenue Next Year
55.94M
from 52.19M
Increased by 7.18%
EPS This Year
-0.32
from -0.66
EPS Next Year
-0.36
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 54.1M | 60.9M | ||||
| Avg | 52.2M | 55.9M | ||||
| Low | 49.8M | 51.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.4% | 16.7% | ||||
| Avg | 8.5% | 7.2% | ||||
| Low | 3.5% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.30 | -0.32 | |
| Avg | -0.32 | -0.36 | |
| Low | -0.32 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.